(Press-News.org) GAINESVILLE, Fla. — A new way to test anti-hearing-loss drugs in people could help land those medicines on pharmacy shelves sooner. University of Florida researchers have figured out the longstanding problem of how to safely create temporary, reversible hearing loss in order to see how well the drugs work. The findings are described in the November/December 2012 issue of the journal Ear & Hearing.
"There's a real need for drug solutions to hearing loss," said lead investigator Colleen Le Prell, Ph.D., an associate professor in the department of speech, language, and hearing sciences at the UF College of Public Health and Health Professions. "Right now the only options for protecting against noise-induced hearing loss are to turn down what you're listening to, walk away from it or wear ear plugs, and those options may not be practical for everyone, particularly for those in the military who need to be able to hear threats."
About 26 million American adults have noise-induced hearing loss, according to the National Institute on Deafness and Other Communication Disorders. Prevention is key because damage to hearing-related hair cells in the inner ear by loud noise is irreversible. Though hearing aids can help amplify sound and implanted devices can restore some sensation of sound for those with more profound hearing loss, they do not restore normal hearing. Thus, researchers are trying to find drugs that prevent hearing damage in the first place.
Although prototype drugs have prevented noise-induced hearing loss in laboratory animals, it has been hard to know whether the same protection is possible in humans, largely because researchers lacked an effective method for the needed tests. Those tests are now achievable because of the UF efforts. The work brings scientists closer to the development of drugs that could help protect people at risk of hearing damage — from rock concert goers to factory workers and military personnel who are routinely exposed to noise as they work.
Le Prell's model is the first to use controlled music levels to reliably cause low-level, temporary hearing loss in human participants. Other studies have used beeps or tones, user-selected music levels, or music exposures that don't result in temporary hearing loss. Three monitoring boards ensured that studies of the UF model met national safety standards for research in humans. Co-investigator Patrick Antonelli, M.D., the George T. Singleton Professor and chair of the UF department of otolaryngology, provided onsite supervision of study participant safety, and collaborators at the University of Michigan and Southern Illinois University were involved in study design and safety discussions.
"Dr. Le Prell started with a unique idea to create a reversible noise-induced hearing loss and has established solid groundwork for this new model in the use of clinical drug testing," said hearing expert Jianxin Bao, Ph.D., an associate professor of otolaryngology and biology and biomedical sciences at Washington University School of Medicine in St. Louis, who was not involved in the UF study. "As for every new model, several unknown factors exist for this elegant experiment model, which requires further detailed studies."
To induce temporary hearing loss, study participants listened to rock or pop music on a digital music player via headphones for four hours at sound levels ranging from 93 decibels — the noise level of a power lawn mower — to 102 decibels, the noise of a jackhammer. Each participant got a hearing test four times, 15 minutes to three-and-a-quarter hours after his or her listening session, as well as follow-up tests one day and one week later. Fifteen minutes after the music stopped, those who listened to the highest music levels had lost just a small amount of hearing — six decibels, on average. Hearing returned to normal within three hours.
Le Prell's group will use this testing model in two first-of-a-kind clinical trials of therapeutics designed to determine if noise-induced hearing loss can be prevented in humans. The first study uses a dietary supplement called Soundbites, manufactured by Hearing Health Science, a University of Michigan bioscience spinoff company. Soundbites contains the vitamin A precursor beta carotene, vitamins C and E and the mineral magnesium. This antioxidant formula, the patent for which Le Prell shares, has prevented temporary and permanent hearing loss in laboratory animals.
In the other ongoing study, participants take a drug called SPI-1005 produced by Sound Pharmaceuticals Inc. The test capsule contains a new molecule called ebselen that mimics a protective inner ear protein.
The Food and Drug Administration will monitor the studies to ensure openness, analytical rigor and participant safety as the researchers try to get badly needed drugs onto the market.
"We really want to find out what's going to work and we want to make it possible for strategies that do work to get in the hands of the people who need them," Le Prell said.
INFORMATION:
Hearing-loss-prevention drugs closer to reality thanks to new UF test
2013-01-17
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
The new age of proteomics: An integrative vision of the cellular world
2013-01-17
The enormous complexity of biological processes requires the use of highperformance technologies —also known as 'omics'—, that are capable of carrying out complete integrated analyses of the thousands of molecules that cells are made up of, and of studying their role in illnesses. In the post-genomic age we find ourselves in, the comprehensive study of cellular proteins —prote-omics— acquires a new dimension, as proteins are the molecular executors of genes and, therefore, the most important pieces of the puzzle if we wish to understand more completely how cells work.
The ...
Implicit race bias increases the differences in the neural representations of black and white faces
2013-01-17
Racial stereotypes have been shown to have subtle and unintended consequences on how we treat members of different race groups. According to new research published in Psychological Science, a journal of the Association for Psychological Science, race bias also increases differences in the brain's representations of faces.
Psychological scientists Tobias Brosch of the University of Geneva in Switzerland and Eyal Bar-David and Elizabeth Phelps of New York University examined activity in the brain while participants looked at pictures of White and Black faces. Afterwards, ...
New insights into the 'borderline personality' brain
2013-01-17
New work by University of Toronto Scarborough researchers gives the best description yet of the neural circuits that underlie a severe mental illness called Borderline Personality Disorder (BPD), and could lead to better treatments and diagnosis.
The work shows that brain regions that process negative emotions (for example, anger and sadness) are overactive in people with BPD, while brain regions that would normally help damp down negative emotions are underactive.
People with BPD tend to have unstable and turbulent emotions which can lead to chaotic relationships with ...
Lack of key enzyme in the metabolism of folic acid leads to birth defects
2013-01-17
AUSTIN, Texas — Researchers at The University of Texas at Austin have discovered that the lack of a critical enzyme in the folic acid metabolic pathway leads to neural tube birth defects in developing embryos.
It has been known for several decades that folic acid supplementation dramatically reduces the incidence of neural tube defects, such as spina bifida and anencephaly, which are among the most common birth defects. In some populations, folic acid supplementation has decreased neural tube defects by as much as 70 percent.
However, scientists still do not fully ...
New UAlberta research shows commonly prescribed medications could have adverse effects
2013-01-17
A research team with the Faculty of Medicine & Dentistry at the University of Alberta reported findings that significantly improve understanding of how widely used drugs in Pulmonary Arterial Hypertension (PAH) affect the heart health of treated patients.
The research shows that medications often prescribed for PAH could block the function of an important hormone in the heart, decreasing the strength of contraction of the right heart chambers, a potentially important and yet unrecognized adverse effect.
PAH is a disease that affects the blood vessels of the lungs, causing ...
Novel technique reveals dynamics of telomere DNA structure
2013-01-17
Biomedical researchers studying aging and cancer are intensely interested in telomeres, the protective caps on the ends of chromosomes. In a new study, scientists at UC Santa Cruz used a novel technique to reveal structural and mechanical properties of telomeres that could help guide the development of new anti-cancer drugs.
Telomeres are long, repetitive DNA sequences at the ends of chromosomes that serve a protective function analogous to that of the plastic tips on shoelaces. As cells divide, their telomeres get progressively shorter, until eventually the cells stop ...
Diabetic fruit flies support buzz about dietary sugar dangers
2013-01-17
LA JOLLA, Calif., January 15, 2013 – Regularly consuming sucrose—the type of sugar found in many sweetened beverages—increases a person's risk of heart disease. In a study published January 10 in the journal PLOS Genetics, researchers at Sanford-Burnham Medical Research Institute and Mount Sinai School of Medicine used fruit flies, a well-established model for human health and disease, to determine exactly how sucrose affects heart function. In addition, the researchers discovered that blocking this cellular mechanism prevents sucrose-related heart problems.
"Our study ...
NFL players may be at higher risk for depression as they age
2013-01-17
SAN DIEGO – National Football League (NFL) players may be at increased risk of depression as they age due to brain damage resulting from concussions, according to two studies released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013.
"The Centers for Disease Control and Prevention estimates that about 1.6 to 3.8 million sports concussions occur each year. While it is known that sports concussions can cause immediate disturbances in mood and thinking, few studies have investigated the long-term ...
Shorter woman, taller man: Preferences for partner height translate into actual partner choices
2013-01-17
Finding Mr. or Ms. Right is a complicated process, and choosing a mate may involve compromising on less important factors like their height. However, research published January 16 in the open access journal PLOS ONE by Gert Stulp and colleagues from the University of Groningen, Netherlands suggests that despite the many other factors involved, people's preferences for a partner's height are reflected in real couples in the UK.
Given the average heights of men and women in typical Western populations, two out of every hundred couples should comprise a woman who is taller ...
Warmest spring on record causes earliest flowering ever observed in eastern U.S.
2013-01-17
Exceptionally warm spring weather in 2010 and 2012 resulted in the earliest flowering times known in 161 years of recorded history at two sites in the eastern US, according to research published January 16 in the open access journal PLOS ONE by Elizabeth Ellwood of Boston University and colleagues.
Many plants need a long winter break to undergo physiological changes that make them bloom in the spring. According to several previous studies, this blooming is occurring earlier than before due to warmer springs caused by climate change. The consequences of such early flowering ...